{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T16:02:09Z","timestamp":1772812929223,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","revespcardiol.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Espa\u00f1ola de Cardiolog\u00eda"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.recesp.2012.02.020","type":"journal-article","created":{"date-parts":[[2012,6,13]],"date-time":"2012-06-13T15:39:48Z","timestamp":1339601988000},"page":"713-718","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Utilizaci\u00f3n de tratamientos cardiovasculares preventivos y consecuci\u00f3n de objetivos terap\u00e9uticos en pacientes con enfermedad arterial perif\u00e9rica"],"prefix":"10.1016","volume":"65","author":[{"given":"Jos\u00e9 M.","family":"Mostaza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrique","family":"Puras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariano","family":"Blasco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Lahoz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda L.","family":"Samaniego","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.recesp.2012.02.020_bib0005","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.atherosclerosis.2010.10.021","article-title":"Prevalence of low ankle-brachial index, elevated plasma fibrinogen and CRP across Framingham risk categories: data from the National Health and Nutrition Examination Survey (NHANES) 1999-2004","volume":"216","author":"Dhangana","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.recesp.2012.02.020_bib0010","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/j.1532-5415.2007.01123.x","article-title":"Prevalence of peripheral arterial disease and risk factors in persons aged 60 and older: data from the National Health and Nutrition Examination Survey 1999-2004","volume":"55","author":"Ostchega","year":"2007","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.recesp.2012.02.020_bib0015","first-page":"20","article-title":"Prevalence of peripheral artery disease and its associated risk factors in Spain: The ESTIME Study","volume":"28","author":"Blanes","year":"2009","journal-title":"Int Angiol"},{"key":"10.1016\/j.recesp.2012.02.020_bib0020","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0025-7753(03)73857-3","article-title":"\u00cdndice tobillo brazo y riesgo cardiovascular","volume":"121","author":"Mostaza","year":"2003","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.recesp.2012.02.020_bib0025","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.recesp.2010.10.024","article-title":"El \u00edndice tobillo-brazo mejora la clasificaci\u00f3n del riesgo cardiovascular: estudio ARTPER\/PERART","volume":"64","author":"Baena-D\u00edez","year":"2011","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.recesp.2012.02.020_bib0030","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.recesp.2012.02.020_bib0035","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/S0195-668X(03)00347-6","article-title":"European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice","volume":"24","author":"De Backer","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.recesp.2012.02.020_bib0040","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.jacc.2005.10.009","volume":"47","author":"Hirsch","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.recesp.2012.02.020_bib0045","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.jvs.2006.12.037","article-title":"Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)","volume":"Suppl 45","author":"Norgren","year":"2007","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.recesp.2012.02.020_bib0050","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1093\/eurheartj\/ehr211","volume":"32","author":"Tendera","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.recesp.2012.02.020_bib0055","doi-asserted-by":"crossref","first-page":"172.e1","DOI":"10.1016\/j.recesp.2011.11.007","article-title":"Gu\u00eda de pr\u00e1ctica cl\u00ednica de la ESC sobre diagn\u00f3stico y tratamiento de las enfermedades arteriales perif\u00e9ricas","volume":"65","author":"Tendera","year":"2012","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.recesp.2012.02.020_bib0060","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1157\/13095812","article-title":"Control de factores de riesgo coronario en prevenci\u00f3n secundaria: estudio PRESENAP","volume":"127","author":"Tranche","year":"2006","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.recesp.2012.02.020_bib0065","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0300-8932(09)71694-X","article-title":"Control de los factores de riesgo y tratamiento de los pacientes con cardiopat\u00eda isqu\u00e9mica: registro TRECE","volume":"62","author":"Bertomeu","year":"2009","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.recesp.2012.02.020_bib0070","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.recesp.2010.07.009","article-title":"Impacto de un tratamiento integral e intensivo de factores de riesgo sobre la mortalidad cardiovascular en prevenci\u00f3n secundaria: estudio MIRVAS","volume":"64","author":"Moreno-Palanco","year":"2011","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.recesp.2012.02.020_bib0075","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ejvs.2009.09.027","article-title":"A systematic review of implementation of established recommended secondary prevention measures in patients with PAOD","volume":"39","author":"Flu","year":"2010","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.recesp.2012.02.020_bib0080","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S0025-7753(07)72882-8","article-title":"Control de factores de riesgo y tratamiento de la aterotrombosis. Registro REACH Espa\u00f1a","volume":"129","author":"Su\u00e1rez","year":"2007","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.recesp.2012.02.020_bib0085","unstructured":"American Diabetes Association: clinical practice recommendations 2002. Diabetes Care. 2002;25 Suppl 1:S1\u2013147."},{"key":"10.1016\/j.recesp.2012.02.020_bib0090","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.recesp.2012.02.020_bib0095","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1161\/CIRCULATIONAHA.110.003954","article-title":"Secondary prevention and mortality in peripheral artery disease: national health and nutrition examination study, 1999 to 2004","volume":"124","author":"Pande","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.recesp.2012.02.020_bib0100","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1161\/CIRCOUTCOMES.109.868505","article-title":"Medication underuse during long-term follow-up in patients with peripheral arterial disease","volume":"2","author":"Hoeks","year":"2009","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.recesp.2012.02.020_bib0105","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.recesp.2010.10.030","article-title":"Prevalencia y caracter\u00edsticas de la dislipemia en pacientes en prevenci\u00f3n primaria y secundaria tratados con estatinas en Espa\u00f1a. Estudio DYSIS-Espa\u00f1a","volume":"64","author":"Gonz\u00e1lez-Juanatey","year":"2011","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.recesp.2012.02.020_bib0110","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1001\/jama.288.4.462","article-title":"Adherence with statin therapy in elderly patients with and without acute coronary syndromes","volume":"288","author":"Jackevicius","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.recesp.2012.02.020_bib0115","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1592\/phco.26.4.483","article-title":"Factors associated with drug adherence and blood pressure control in patients with hypertension","volume":"26","author":"Morris","year":"2006","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.recesp.2012.02.020_bib0120","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.recesp.2011.05.033","article-title":"An\u00e1lisis de la disminuci\u00f3n de la mortalidad por enfermedad coronaria en una poblaci\u00f3n mediterr\u00e1nea: Espa\u00f1a 1988-2005","volume":"64","author":"Flores-Mateo","year":"2011","journal-title":"Rev Esp Cardiol"}],"container-title":["Revista Espa\u00f1ola de Cardiolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300893212001935?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300893212001935?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T00:56:04Z","timestamp":1759539364000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300893212001935"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":24,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S0300893212001935"],"URL":"https:\/\/doi.org\/10.1016\/j.recesp.2012.02.020","relation":{},"ISSN":["0300-8932"],"issn-type":[{"value":"0300-8932","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Utilizaci\u00f3n de tratamientos cardiovasculares preventivos y consecuci\u00f3n de objetivos terap\u00e9uticos en pacientes con enfermedad arterial perif\u00e9rica","name":"articletitle","label":"Article Title"},{"value":"Revista Espa\u00f1ola de Cardiolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.recesp.2012.02.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Sociedad Espa\u00f1ola de Cardiolog\u00eda. Published by Elsevier Espa\u00f1a, S.L. All rights reserved.","name":"copyright","label":"Copyright"}]}}